Drug Profile
Dextrin 2-sulfate
Alternative Names: D2S; Emmelle; ViraldonLatest Information Update: 03 Dec 2021
Price :
$50
*
At a glance
- Originator Innovata
- Class Antivirals; Dextrins
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chlamydial infections; HIV infections
Most Recent Events
- 19 Jan 2007 Innovata has been acquired by Vectura
- 14 Jul 2005 Innovata Biomed has merged with ML Laboratories to form Innovata
- 15 Sep 2004 Discontinued - Phase-II for HIV infections treatment in USA (Intraperitoneal)